UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Social phobia in the general population : prevalence and sociodemographic profile

Social Psychiatry and Psychiatric Epidemiology, 1999-08, Vol.34 (8), p.416-424

1999

Volltextzugriff (PDF)

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia

Psychopharmacologia, 1998, Vol.135 (2), p.119-126

1998

Volltextzugriff (PDF)

Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection

Journal of pharmaceutical and biomedical analysis, 1999-06, Vol.20 (1), p.271-282

1999

Volltextzugriff (PDF)

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

The journal of clinical psychiatry, 2003-10, Vol.64 (10), p.1250-1257

2003

Volltextzugriff (PDF)

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β- 11C) DOPA and PET

Biological psychiatry (1969), 1999-09, Vol.46 (5), p.681-688

1999

Volltextzugriff (PDF)

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia

The international journal of neuropsychopharmacology, 2005-03, Vol.8 (1), p.27-36

2005

Volltextzugriff (PDF)

L-[β-11C]DOPA Utilization in Schizophrenia

NeuroImage (Orlando, Fla.), 1998-05, Vol.7 (4), p.A45-A45

1998

Volltextzugriff (PDF)

Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine

Scandinavian journal of psychology, 2003-07, Vol.44 (3), p.289-292

2003

Volltextzugriff (PDF)

Dopamine synthesis rate in prefrontal cortex in schizophrenia by use of PET

European psychiatry, 2002-05, Vol.17, p.7-7

2002

Volltextzugriff (PDF)

N-[ 11C]Methylspiperone PET, in contrast to [ 11C]raclopride, fails to detect D 2 receptor occupancy by an atypical neuroleptic

Psychiatry research. Neuroimaging, 1998, Vol.82 (3), p.147-160

1998

Volltextzugriff (PDF)

Long-term safety of long-acting risperidone microspheres

European psychiatry, 2002-05, Vol.17, p.193-193

2002

Volltextzugriff (PDF)

D 2 Receptor Occupancy Determined by 11 C-Raclopride PET and Reference Region Methods

NeuroImage (Orlando, Fla.), 1998-05, Vol.7 (4), p.A20

1998

Volltextzugriff (PDF)

D2 Receptor Occupancy Determined by 11C-Raclopride PET and Reference Region Methods

NeuroImage (Orlando, Fla.), 1998-05, Vol.7 (4), p.A20-A20

1998

Volltextzugriff (PDF)

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

European neuropsychopharmacology, 2001-04, Vol.11 (2), p.105-110

2001

Volltextzugriff (PDF)

Time course of central nervous dopamine-D 2 and 5-HT 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel ® ) in patients with schizophrenia

Psychopharmacology, 1998-01, Vol.135 (2), p.119-126

1998

Volltextzugriff (PDF)

Time course of central nervous dopamine-D sub(2) and 5-HT sub(2) receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel registered ) in patients with schizophrenia

Psychopharmacology, 1998-01, Vol.135 (2), p.119-126

1998

Volltextzugriff (PDF)

Increased synthesis of dopamine in prefrontal cortex and striatum in drug-naive schizophrenic patients studied by use of C 11-labelled I-DOPA and positron emission tomography (PET)

Schizophrenia research, 1998, Vol.29 (1), p.93-94

1998

Volltextzugriff (PDF)

Increased synthesis of dopamine in prefrontal cortex and striatum in drug-naive schizophrenic patients studied by use of C11-labelled I-DOPA and positron emission tomography (PET)

Schizophrenia research, 1998-01, Vol.29 (1-2), p.93-94

1998

Volltextzugriff (PDF)

( 11C)-N-Methylspiperone pet detects different levels of dopamine D 2 receptor occupancy of an atypical neuroleptic than ( 11C)-raclopride pet

Schizophrenia research, 1998, Vol.29 (1), p.165-166

1998

Volltextzugriff (PDF)

(11C)-N-Methylspiperone pet detects different levels of dopamine D2 receptor occupancy of an atypical neuroleptic than (11C)-raclopride pet

Schizophrenia research, 1998-01, Vol.29 (1-2), p.165-166

1998

Volltextzugriff (PDF)

Relationships between dopamine-D2 receptor blockade and dopamine synthesis during neuroleptic treatment

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.230

1997

Volltextzugriff (PDF)

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

Psychiatry research, 1998-06, Vol.82 (3), p.147-160

1998

Volltextzugriff (PDF)

Relationships between dopamine-D 2 receptor blockade and dopamine synthesis during neuroleptic treatment

Biological psychiatry (1969), 1997, Vol.42 (1), p.230S-230S

1997

Volltextzugriff (PDF)

N-[11C]methyispiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

Psychiatry research, 1998, Vol.82 (3), p.147-160

1998

Volltextzugriff (PDF)

Differences in 5HT2a receptor binding between schizophrenics and healthy volunteers in a PET study in the frontal and temporal cortex

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.186

1997

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(32)
Tagungsberichte
(4)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Social phobia in the general population : prevalence and sociodemographic profile

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia

Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β- 11C) DOPA and PET

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia

L-[β-11C]DOPA Utilization in Schizophrenia

Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine

Dopamine synthesis rate in prefrontal cortex in schizophrenia by use of PET

N-[ 11C]Methylspiperone PET, in contrast to [ 11C]raclopride, fails to detect D 2 receptor occupancy by an atypical neuroleptic

Long-term safety of long-acting risperidone microspheres

D 2 Receptor Occupancy Determined by 11 C-Raclopride PET and Reference Region Methods

D2 Receptor Occupancy Determined by 11C-Raclopride PET and Reference Region Methods

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

Time course of central nervous dopamine-D 2 and 5-HT 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel ® ) in patients with schizophrenia

Time course of central nervous dopamine-D sub(2) and 5-HT sub(2) receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel registered ) in patients with schizophrenia

Increased synthesis of dopamine in prefrontal cortex and striatum in drug-naive schizophrenic patients studied by use of C 11-labelled I-DOPA and positron emission tomography (PET)

Increased synthesis of dopamine in prefrontal cortex and striatum in drug-naive schizophrenic patients studied by use of C11-labelled I-DOPA and positron emission tomography (PET)

( 11C)-N-Methylspiperone pet detects different levels of dopamine D 2 receptor occupancy of an atypical neuroleptic than ( 11C)-raclopride pet

(11C)-N-Methylspiperone pet detects different levels of dopamine D2 receptor occupancy of an atypical neuroleptic than (11C)-raclopride pet

Relationships between dopamine-D2 receptor blockade and dopamine synthesis during neuroleptic treatment

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

Relationships between dopamine-D 2 receptor blockade and dopamine synthesis during neuroleptic treatment

N-[11C]methyispiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

Differences in 5HT2a receptor binding between schizophrenics and healthy volunteers in a PET study in the frontal and temporal cortex

Suchergebnisse filtern